{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-20",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "QXC",
      "openfda": {
        "k_number": [
          "DEN220058"
        ]
      },
      "review_panel": "CH",
      "medical_specialty": "HO",
      "device_name": "Diabetes Digital Therapeutic Device",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "General Hospital",
      "device_class": "2",
      "definition": "A diabetes digital behavioral therapeutic device is a prescription use software device that provides digital behavioral therapy to aid in the management of diabetes. This device is intended to provide limited secondary benefit to patients  with diabetes mellitus by assisting them in managing their condition. This device is not intended to replace any  primary treatment, such as diet/lifestyle changes or medication.",
      "regulation_number": "880.5735",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}